InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Arbutus Biopharma Corp

ABUS Clue Score44
United States Fiscal year ends December CIK 0001447028
$4.22 +0.96% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.22 +0.48% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.5Operating income−491.6Net income−384.2EPS, diluted−7.24Fiscal year 2017Revenue10.7 +617.6%Operating income−110.9Net income−84.4EPS, diluted−1.56Fiscal year 2018Revenue5.9 −44.4%Operating income−89.8Net income−57.1EPS, diluted−1.21Fiscal year 2019Revenue6.0 +1.1%Operating income−143.9Net income−153.7Fiscal year 2020Revenue6.9 +15.0%Operating income−57.8Net income−63.7EPS, diluted−1.00Fiscal year 2021Revenue11.0 +58.9%Operating income−73.5Net income−76.2EPS, diluted−0.83Fiscal year 2022Revenue39.0 +255.1%Operating income−65.5Net income−69.5EPS, diluted−0.46Fiscal year 2023Revenue18.1 −53.5%Operating income−78.1Net income−72.8EPS, diluted−0.44Fiscal year 2024Revenue6.2 −66.0%Operating income−76.3Net income−69.9EPS, diluted−0.38Fiscal year 2025Revenue14.1 +128.2%Operating income−38.2Net income−33.5EPS, diluted−0.17
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.5 10.7 5.9 6.0 6.9 11.0 39.0 18.1 6.2 14.1
Growth +617.6% −44.4% +1.1% +15.0% +58.9% +255.1% −53.5% −66.0% +128.2%
Operating income −491.6 −110.9 −89.8 −143.9 −57.8 −73.5 −65.5 −78.1 −76.3 −38.2
Net income −384.2 −84.4 −57.1 −153.7 −63.7 −76.2 −69.5 −72.8 −69.9 −33.5
Growth
EPS, diluted −7.24 −1.56 −1.21 n/a −1.00 −0.83 −0.46 −0.44 −0.38 −0.17
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−32,973.8%Net margin−25,765.5%Free cash flow margin−4,150.3%Fiscal year 2017Operating margin−1,036.7%Net margin−788.9%Free cash flow margin−522.5%Fiscal year 2018Operating margin−1,510.2%Net margin−959.8%Free cash flow margin−1,160.7%Fiscal year 2019Operating margin−2,394.0%Net margin−2,557.4%Free cash flow margin−1,191.1%Fiscal year 2020Operating margin−836.1%Net margin−922.0%Free cash flow margin−747.3%Fiscal year 2021Operating margin−669.1%Net margin−693.9%Free cash flow margin−622.0%Fiscal year 2022Operating margin−167.8%Net margin−178.0%Free cash flow margin−91.9%Fiscal year 2023Operating margin−430.5%Net margin−401.6%Free cash flow margin−479.3%Fiscal year 2024Operating margin−1,236.7%Net margin−1,133.0%Free cash flow margin−1,053.8%Fiscal year 2025Operating margin−271.0%Net margin−237.9%Free cash flow margin−281.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −32,973.8% −1,036.7% −1,510.2% −2,394.0% −836.1% −669.1% −167.8% −430.5% −1,236.7% −271.0%
Net margin −25,765.5% −788.9% −959.8% −2,557.4% −922.0% −693.9% −178.0% −401.6% −1,133.0% −237.9%
Free cash flow margin −4,150.3% −522.5% −1,160.7% −1,191.1% −747.3% −622.0% −91.9% −479.3% −1,053.8% −281.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−57.9Capital expenditure−4.0Free cash flow−61.9Fiscal year 2017Operating cash flow−48.6Capital expenditure−7.3Free cash flow−55.9Fiscal year 2018Operating cash flow−67.9Capital expenditure−1.1Free cash flow−69.0Fiscal year 2019Operating cash flow−71.0Capital expenditure−0.6Free cash flow−71.6Fiscal year 2020Operating cash flow−51.4Capital expenditure−0.2Free cash flow−51.7Fiscal year 2021Operating cash flow−67.5Capital expenditure−0.8Free cash flow−68.3Fiscal year 2022Operating cash flow−35.4Capital expenditure−0.5Free cash flow−35.9Fiscal year 2023Operating cash flow−85.9Capital expenditure−1.0Free cash flow−86.9Fiscal year 2024Operating cash flow−64.9Capital expenditure−0.2Free cash flow−65.0Fiscal year 2025Operating cash flow−39.6Capital expenditure0.0Free cash flow−39.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −57.9 −48.6 −67.9 −71.0 −51.4 −67.5 −35.4 −85.9 −64.9 −39.6
Capital expenditure −4.0 −7.3 −1.1 −0.6 −0.2 −0.8 −0.5 −1.0 −0.2 0.0
Free cash flow −61.9 −55.9 −69.0 −71.6 −51.7 −68.3 −35.9 −86.9 −65.0 −39.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash23.4Shareholders’ equity203.0Fiscal year 2017Cash54.3Shareholders’ equity182.5Fiscal year 2018Cash36.9Shareholders’ equity200.2Fiscal year 2019Cash31.8Shareholders’ equity72.7Fiscal year 2020Cash52.3Shareholders’ equity102.0Fiscal year 2021Cash109.3Total debt0.0Net cash (debt)109.3Shareholders’ equity169.4Debt to equity0.00Fiscal year 2022Cash30.8Total debt0.0Net cash (debt)30.8Shareholders’ equity136.9Debt to equity0.00Fiscal year 2023Cash26.3Total debt0.0Net cash (debt)26.3Shareholders’ equity106.0Debt to equity0.00Fiscal year 2024Cash36.3Total debt0.0Net cash (debt)36.3Shareholders’ equity97.4Debt to equity0.00Fiscal year 2025Cash18.0Total debt0.0Net cash (debt)18.0Shareholders’ equity76.6Debt to equity0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 23.4 54.3 36.9 31.8 52.3 109.3 30.8 26.3 36.3 18.0
Total debt n/a n/a n/a n/a n/a 0.0 0.0 0.0 0.0 0.0
Net cash (debt) n/a n/a n/a n/a n/a 109.3 30.8 26.3 36.3 18.0
Shareholders’ equity 203.0 182.5 200.2 72.7 102.0 169.4 136.9 106.0 97.4 76.6
Debt to equity n/a n/a n/a n/a n/a 0.00 0.00 0.00 0.00 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.5 10.7 5.9 6.0 6.9 11.0 39.0 18.1 6.2 14.1
Growth +617.6% −44.4% +1.1% +15.0% +58.9% +255.1% −53.5% −66.0% +128.2%
61.3 62.7 57.9 57.6 49.3 65.5 84.4 73.7 54.0 25.2
39.4 16.1 16.0 17.7 14.8 17.1 17.8 22.5 22.1 15.9
−491.6 −110.9 −89.8 −143.9 −57.8 −73.5 −65.5 −78.1 −76.3 −38.2
Growth
−489.2 −108.7 −61.3 −166.4 −63.7 n/a n/a n/a n/a n/a
−105.0 −24.3 −4.3 −12.7 0.0 0.0 4.4 0.0 0.0 0.0
−384.2 −84.4 −57.1 −153.7 −63.7 −76.2 −69.5 −72.8 −69.9 −33.5
Growth
Per share
−7.24 −1.56 −1.21 n/a −1.00 −0.83 −0.46 −0.44 −0.38 −0.17
−7.24 −1.56 −1.21 n/a −1.00 −0.83 −0.46 −0.44 −0.38 −0.17
Growth
53.1 54.7 55.3 n/a 75.8 106.2 150.9 166.0 185.6 191.6
53.1 54.7 55.3 n/a 75.8 106.2 150.9 166.0 185.6 191.6
Growth +3.1% +1.1% +40.1% +42.1% +10.0% +11.8% +3.2%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 15.3% a year over five years.
  • The diluted share count rose 152.7% in five years, which is dilution.
  • Operating margin is up 565.1 points on five years ago, at -271.0%.
  • A net loss in 10 of 10 years on file.